Company news
Resonance Health Ltd news in 2021
Resonance Health Ltd's news releases, calls and decks from 2021, newest first.
US FDA Clearance for LiverSmart
December 29, 2021
ASO Project New Data
December 19, 2021
LiverSmart Submitted to FDA for US Regulatory Clearance
December 2, 2021
Investor Presentation - Positioning for Growth
November 25, 2021
ASO R&D Project - Filing of Two Patent Applications
November 22, 2021
Thalassaemia International Federation to Deploy FerriSmart
November 11, 2021
Sales & Marketing Update
October 13, 2021
New AI Medical Device
October 12, 2021
Appointment of GM - Global Sales & Marketing
July 27, 2021
Appointment of Managing Director
June 27, 2021
Resignation of CEO & Management Changes
June 3, 2021
Filing of Patent Application
May 23, 2021
R&D Update - Molecular Medicine ASO Project
May 16, 2021
Appendix 4C - quarterly
April 28, 2021
Resonance Health: HepaFat-AI Receives CE Marking
February 24, 2021
HepaFat-AI receives CE Marking
February 23, 2021
HepaFat-AI Receives TGA Approval
February 18, 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 19 slides · Nov 25, 2021